Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
INDIGO adjuvanted pandemic influenza vaccine
- Development stage
- Preclinical
- Lead developer
- LiteVax
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The INDIGO adjuvanted pandemic influenza vaccine is a prophylactic vaccine candidate developed by LiteVax as part of the INDIGO consortium, funded by the EU Horizon 2020 program. The vaccine utilizes LiteVax's proprietary CMS (carbohydrate fatty acid monosulphate ester) adjuvant, which is an oil-in-water emulsion designed to significantly boost immune responses to pandemic influenza antigens. This adjuvant technology is intended to provide dose-sparing benefits, allowing for the production of more vaccine doses with less antigen, which is a critical advantage in pandemic scenarios to improve global accessibility and cost-effectiveness. The program is currently in the preclinical stage of development.
- Other names
- LiteVax pandemic influenza vaccine
02
Targets
Flu (Influenza surface proteins)
Beyond the preview
Go deeper on INDIGO adjuvanted pandemic influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INDIGO adjuvanted pandemic influenza vaccine.